Concepedia

Jayaganesh V. Natarajan

JV

7

Publications

757

Citations

7

H-Index

2003

Active since

Affiliations

Singapore National Eye Center(Current)

Nanyang Technological University

Singapore Eye Research Institute

Case Western Reserve University

Jayaganesh V. Natarajan is an author at Singapore National Eye Center specializing in pharmacology, medicine, and drug discovery.

Top concepts

PharmacologyMedicineGlaucomaNanomedicineOphthalmologyDrug DiscoveryOcular PharmacologyBiochemistryOptogeneticsDrug Analysis

Publications per year

2003–2017

7

Publications

7

Controlled targeting of liposomal doxorubicin via the folate receptor in vitro

Justin M. Saul, Ananth Annapragada, Jayaganesh V. Natarajan et al. · Journal of Controlled Release · 2003 · 303 citations

Lipid Preparation, Folate Receptor, Drug Targeting +3

Sustained Drug Release in Nanomedicine: A Long-Acting Nanocarrier-Based Formulation for Glaucoma

Jayaganesh V. Natarajan, Anastasia Darwitan, Veluchamy A. Barathi et al. · ACS Nano · 2014 · 126 citations

Folate targeting of drug carriers: A mathematical model

Ketan B. Ghaghada, Justin M. Saul, Jayaganesh V. Natarajan et al. · Journal of Controlled Release · 2005 · 94 citations

Drug Targeting, Folate Targeting, Medicine +4

Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye

Jayaganesh V. Natarajan, Sujay Chattopadhyay, Marcus Ang et al. · PLoS ONE · 2011 · 94 citations · Full text

Ocular Disease, Pharmacotherapy, Ocular Pharmacology +16

Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops

Tina Wong, Gary D. Novack, Jayaganesh V. Natarajan et al. · Drug Delivery and Translational Research · 2014 · 73 citations

Nanomedicine, Optogenetics, Sustained Release Latanoprost +10

Rows per page

1–5 of 7